As of May 2022 Jiangsu Hengrui Medicine has a market cap of $28.86 Billion. This makes Jiangsu Hengrui Medicine the world's 590th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $28.17 B | -44.65% |
2021 | $50.90 B | -44.14% |
2020 | $91.11 B | 64.44% |
2019 | $55.41 B | 96.2% |
2018 | $28.24 B | -5.06% |
2017 | $29.74 B | 93.44% |
2016 | $15.37 B | 3.71% |
2015 | $14.82 B | 62.88% |
2014 | $9.10 B | 6.64% |
2013 | $8.53 B | 42.99% |
2012 | $5.96 B | 13.8% |
2011 | $5.24 B | -22.29% |
2010 | $6.75 B | 41.48% |
2009 | $4.77 B | 63.18% |
2008 | $2.92 B | -12.7% |
2007 | $3.34 B | 144.13% |
2006 | $1.37 B | 194.2% |
2005 | $0.46 B | 21.19% |
2004 | $0.38 B | 48.64% |
2003 | $0.25 B | -16.33% |
2002 | $0.30 B | -28.92% |
2001 | $0.43 B |
On May 19th, 2022 the market cap of Jiangsu Hengrui Medicine was reported to be: